ArticleCancer management and research2018

Tumor-infiltrating lymphocyte as a prognostic biomarker in stage IV colorectal cancer should take into account the metastatic status and operation modality.

Qian-Kun Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.